Ategenos

Ategenos is a pre-clinical digital therapeutics company developing the SmartPatch™ platform, a transdermal, wirelessly connected drug delivery system that combines sustained drug release with real-time adherence monitoring and AI-powered caregiver alerts. The technology is currently under development and not yet available for commercial sale; regulatory submission is pending. The company aims to address the global crisis of medication non-adherence, with a focus on chronic and critical dose medications where missed doses can lead to serious health events. Partnerships with pharmaceutical companies are being established for lifecycle extension and reformulation of oral solid dose drugs in behavioral health, cardiovascular, CNS, and oncology indications[1][2][3].